Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 275
8
Diseases
23
Unique genes
0.231
Avg. similarity score
Bestrophinopathy
Most-connected disease (7 links)
Disease
Searched: Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma
Bestrophinopathy
Iron overload
Vitreoretinochoroidopathy
Hemochromatosis type 5
Neurodegeneration with brain iron accumulation 9
Neurodegeneration with brain iron accumulation
Vitelliform macular dystrophy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bestrophinopathy | 7 | 7 | 4 |
| Iron overload | 6 | 6 | 7 |
| Vitreoretinochoroidopathy | 6 | 6 | 2 |
| Hemochromatosis type 5 | 4 | 4 | 1 |
| Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma | 4 | 4 | 1 |
| Neurodegeneration with brain iron accumulation 9 | 4 | 4 | 1 |
| Neurodegeneration with brain iron accumulation | 3 | 3 | 14 |
| Vitelliform macular dystrophy | 2 | 2 | 5 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| BEST1 | 6 / 8 | Bestrophinopathy, Iron overload, Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, Neurodegeneration with brain iron accumulation and 2 more |
| FTH1 | 6 / 8 | Bestrophinopathy, Hemochromatosis type 5, Iron overload, Neurodegeneration with brain iron accumulation and 2 more |
| CP | 2 / 8 | Iron overload, Neurodegeneration with brain iron accumulation |
| PRPH2 | 2 / 8 | Bestrophinopathy, Vitelliform macular dystrophy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Iron uptake and transport | Reactome | 5 / 28 | 93.2× | 1.54e-9 | 1.38e-7 ✓ sig. |
| Ferroptosis | KEGG | 5 / 42 | 62.2× | 1.31e-8 | 9.46e-7 ✓ sig. |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | Reactome | 2 / 2 | 522× | 3.51e-6 | 1.22e-4 ✓ sig. |
| Defective CP causes aceruloplasminemia (ACERULOP) | Reactome | 2 / 2 | 522× | 3.51e-6 | 1.22e-4 ✓ sig. |
| Mineral absorption | KEGG | 4 / 61 | 34.2× | 4.96e-6 | 1.63e-4 ✓ sig. |
| Porphyrin metabolism | KEGG | 3 / 46 | 34.1× | 8.83e-5 | 1.72e-3 ✓ sig. |
| Coenzyme A biosynthesis | Reactome | 2 / 8 | 131× | 9.75e-5 | 1.86e-3 ✓ sig. |
| Metal ion SLC transporters | Reactome | 2 / 9 | 116× | 1.25e-4 | 2.26e-3 ✓ sig. |
| Pantothenate and CoA biosynthesis | KEGG | 2 / 21 | 49.7× | 7.21e-4 | 8.84e-3 ✓ sig. |
| TGF-beta signaling pathway | KEGG | 3 / 108 | 14.5× | 1.10e-3 | 1.22e-2 ✓ sig. |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | Reactome | 1 / 2 | 261× | 3.83e-3 | 3.03e-2 ✓ sig. |
| Golgi Associated Vesicle Biogenesis | Reactome | 2 / 56 | 18.6× | 5.07e-3 | 3.68e-2 ✓ sig. |
| Beta-oxidation of pristanoyl-CoA | Reactome | 1 / 9 | 58.0× | 1.71e-2 | 7.84e-2 |
| Cargo recognition for clathrin-mediated endocytosis | Reactome | 2 / 106 | 9.9× | 1.73e-2 | 7.88e-2 |
| Post-translational protein phosphorylation | Reactome | 2 / 108 | 9.7× | 1.79e-2 | 8.05e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| intracellular iron ion homeostasis | GO:0006879 | 8 / 71 | 91.5× | 1.35e-14 | 9.05e-12 ✓ sig. |
| iron ion export across plasma membrane | GO:1903988 | 3 / 3 | 812× | 1.63e-9 | 3.55e-7 ✓ sig. |
| multicellular organismal-level iron ion homeostasis | GO:0060586 | 4 / 28 | 116× | 3.50e-8 | 5.23e-6 ✓ sig. |
| iron ion transport | GO:0006826 | 4 / 31 | 105× | 5.37e-8 | 7.54e-6 ✓ sig. |
| detection of light stimulus involved in visual perception | GO:0050908 | 3 / 24 | 102× | 3.24e-6 | 2.23e-4 ✓ sig. |
| visual perception | GO:0007601 | 5 / 215 | 18.9× | 5.47e-6 | 3.40e-4 ✓ sig. |
| cellular response to iron ion | GO:0071281 | 2 / 7 | 232× | 3.03e-5 | 1.26e-3 ✓ sig. |
| coenzyme A biosynthetic process | GO:0015937 | 2 / 10 | 162× | 6.48e-5 | 2.24e-3 ✓ sig. |
| retina morphogenesis in camera-type eye | GO:0060042 | 2 / 14 | 116× | 1.31e-4 | 3.74e-3 ✓ sig. |
| photoreceptor cell outer segment organization | GO:0035845 | 2 / 15 | 108× | 1.51e-4 | 4.16e-3 ✓ sig. |
| response to iron ion | GO:0010039 | 2 / 18 | 90.3× | 2.19e-4 | 5.40e-3 ✓ sig. |
| response to low light intensity stimulus | GO:0009645 | 1 / 1 | 812× | 1.23e-3 | 1.64e-2 ✓ sig. |
| negative regulation of iron ion transmembrane transport | GO:0034760 | 1 / 1 | 812× | 1.23e-3 | 1.64e-2 ✓ sig. |
| negative regulation of iron export across plasma membrane | GO:1904039 | 1 / 1 | 812× | 1.23e-3 | 1.64e-2 ✓ sig. |
| negative regulation of intestinal absorption | GO:1904479 | 1 / 1 | 812× | 1.23e-3 | 1.64e-2 ✓ sig. |